These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2428937)

  • 41. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
    Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
    Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H
    Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.
    Guttman M; Fibiger HC; Jakubovic A; Calne DB
    J Neurochem; 1990 Apr; 54(4):1329-34. PubMed ID: 1690267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets.
    Rose S; Nomoto M; Jenner P; Marsden CD
    Biochem Pharmacol; 1989 Nov; 38(21):3677-81. PubMed ID: 2597167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The neuronal mechanism underlying parkinsonism and dyskinesia: differential roles of the putamen and caudate nucleus.
    Yoshida M
    Neurosci Res; 1991 Oct; 12(1):31-40. PubMed ID: 1660992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.
    Chiueh CC; Markey SP; Burns RS; Johannessen JN; Pert A; Kopin IJ
    Eur J Pharmacol; 1984 Apr; 100(2):189-94. PubMed ID: 6203759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys.
    Gerhardt GA; Cass WA; Hudson J; Henson M; Zhang Z; Ovadia A; Hoffer BJ; Gash DM
    J Neurochem; 1996 Feb; 66(2):579-88. PubMed ID: 8592127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
    Mayer RA; Walters AS; Heikkila RE
    Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Brain Res; 1987 Jul; 415(2):293-9. PubMed ID: 3496938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD; De Ceballos ML; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1992 Aug; 219(2):183-92. PubMed ID: 1385171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical analysis.
    Roeling TA; Docter GJ; Voorn P; Melchers BP; Wolters EC; Groenewegen HJ
    J Chem Neuroanat; 1995 Oct; 9(3):155-64. PubMed ID: 8588831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset.
    Fine A; Reynolds GP; Nakajima N; Jenner P; Marsden CD
    Neurosci Lett; 1985 Jul; 58(1):123-6. PubMed ID: 3931004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia.
    Johansson PE; Terenius L; Häggström JE; Gunne L
    Neuroscience; 1990; 37(2):563-7. PubMed ID: 1723515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD; Ramirez VD
    Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
    Schwartzman RJ; Alexander GM
    Brain Res; 1985 Dec; 358(1-2):137-43. PubMed ID: 3878182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease-related from age-related changes in basal ganglia function.
    Andersen AH; Hardy PA; Forman E; Gerhardt GA; Gash DM; Grondin RC; Zhang Z
    Neurobiol Aging; 2015 Feb; 36(2):1174-82. PubMed ID: 25443764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
    Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD
    Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.